XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 29.81

-4.3%

Dec 2 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: aknahow who wrote (16305)	10/3/2003 3:37:38 PM
From: Cacaito	of 17367

Opportunity for a lottery ticket hit is the chance of the "probe". "Phase I/II" means that there is so much information about bpi safety in children that they are sure the "safety" part will be ok, then they will expand the cases as convenient as possible, the next meeting of the Pediatric Research Society is the most convenient time to decide, the next convenient time is the short time for the corresponding graduating fellow to finish the paper and go on to his new job. There are tons of trials of this kind ongoing all the time, xoma's one get the pr cause is the appropriate thing to do. Look, xoma is doing a formal phase I about the same thing with Millenium drug, but via complement/citokine blocking or something like that, and no one care about it anymore, except the $5 millions out of Raptiva I predicted xoma will waste and milleniun collect, now is a fact. xoma bpi saga is just more of the same.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next